These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 26104328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies.
    Wu X, Franka R, Henderson H, Rupprecht CE.
    Vaccine; 2011 Jun 06; 29(25):4195-201. PubMed ID: 21514343
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
    Franka R, Wu X, Jackson FR, Velasco-Villa A, Palmer DP, Henderson H, Hayat W, Green DB, Blanton JD, Greenberg L, Rupprecht CE.
    Vaccine; 2009 Nov 27; 27(51):7149-55. PubMed ID: 19925945
    [Abstract] [Full Text] [Related]

  • 5. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L, Wang X, Wen Z, Ge J, Wang J, Zhao D, Bu Z.
    Antiviral Res; 2017 Oct 27; 146():36-44. PubMed ID: 28822816
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination.
    Cliquet F, Robardet E, Picard Meyer E.
    Antiviral Res; 2013 Oct 27; 100(1):84-9. PubMed ID: 23899697
    [Abstract] [Full Text] [Related]

  • 8. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L, Feng N, Wang X, Ge J, Wen Z, Chen W, Qin L, Xia X, Bu Z.
    Antiviral Res; 2015 Sep 27; 121():9-15. PubMed ID: 26093157
    [Abstract] [Full Text] [Related]

  • 9. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
    Wang S, Sun C, Zhang S, Zhang X, Liu Y, Wang Y, Zhang F, Wu X, Hu R.
    Arch Virol; 2015 Sep 27; 160(9):2315-23. PubMed ID: 26143474
    [Abstract] [Full Text] [Related]

  • 10. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
    Tian L, Yan L, Zheng W, Lei X, Fu Q, Xue X, Wang X, Xia X, Zheng X.
    Vet Microbiol; 2021 Jun 27; 257():109076. PubMed ID: 33957572
    [Abstract] [Full Text] [Related]

  • 11. An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice.
    Xue XH, Zheng XX, Wang HL, Ma JZ, Li L, Gai WW, Wang TC, Yang ST, Xia XZ.
    Virus Genes; 2014 Jun 27; 48(3):411-20. PubMed ID: 24535572
    [Abstract] [Full Text] [Related]

  • 12. Comparison of immune responses to attenuated rabies virus and street virus in mouse brain.
    Miao FM, Zhang SF, Wang SC, Liu Y, Zhang F, Hu RL.
    Arch Virol; 2017 Jan 27; 162(1):247-257. PubMed ID: 27722994
    [Abstract] [Full Text] [Related]

  • 13. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine.
    Biswas S, Reddy GS, Srinivasan VA, Rangarajan PN.
    Hum Gene Ther; 2001 Oct 10; 12(15):1917-22. PubMed ID: 11589833
    [Abstract] [Full Text] [Related]

  • 14. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S, Warnock E, Osinubi MOV, Rupprecht CE.
    Vaccine; 2017 Aug 03; 35(34):4315-4320. PubMed ID: 28688782
    [Abstract] [Full Text] [Related]

  • 15. Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy.
    Nakagawa K, Ito N, Masatani T, Abe M, Yamaoka S, Ito Y, Okadera K, Sugiyama M.
    Vaccine; 2012 May 21; 30(24):3610-7. PubMed ID: 22464967
    [Abstract] [Full Text] [Related]

  • 16. Vaccination challenge studies with variants of street rabies virus isolated in Nigeria.
    Okoh AE, Umoh JU, Ezeokoli CD, Addo PB.
    Vaccine; 1988 Feb 21; 6(1):19-24. PubMed ID: 3354253
    [Abstract] [Full Text] [Related]

  • 17. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
    Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP.
    Vaccine; 2008 Nov 25; 26(50):6405-14. PubMed ID: 18804506
    [Abstract] [Full Text] [Related]

  • 18. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
    Tao L, Ge J, Wang X, Wen Z, Zhai H, Hua T, Zhao B, Kong D, Yang C, Bu Z.
    Virol J; 2011 Sep 25; 8():454. PubMed ID: 21943337
    [Abstract] [Full Text] [Related]

  • 19. Genetic characterisation of the rabies virus vaccine strains used for oral immunization of foxes in Poland to estimate the effectiveness of vaccination.
    Orłowska A, Żmudziński JF.
    Arch Virol; 2015 Feb 25; 160(2):509-15. PubMed ID: 25408374
    [Abstract] [Full Text] [Related]

  • 20. [Immune efficacy of rabies virus glycoprotein expressed by baculovirus vector].
    Chen Q, Zhang SF, Liu Y, Fu YH, Sun CL, Yang Y, Gong T, Song FF, Hu RL.
    Bing Du Xue Bao; 2012 Sep 25; 28(5):501-5. PubMed ID: 23233923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.